Biaxin, Clarithromycin News

Korea United Pharm Inc. said yesterday that it has obtained two patents on drug manufacturing processes.

Cempra Pharmaceuticals Inc. raised $46 million in a Series C financing to continue clinical trials with the two antibiotic programs it licensed three years ago from Optimer Pharmaceuticals Inc.

Abstract Clarithromycin increased the median survival of patients with unresectable non-small-cell lung cancer who had received chemotherapy and/or radiotherapy [Chemotherapy 1997;43:288-296]. The present study was performed to ascertain whether CAM alone exhibits an antitumor effect against Lewis lung carcinoma and to analyze the nature of its ...

Main Category: GastroIntestinal / Gastroenterology Also Included In: Pain / Anesthetics ; Genetics ; Infectious Diseases / Bacteria / Viruses Article Date: 04 Mar 2009 - 2:00 PST Resent studies reported that ...

Abstract Contrary to other species in the Mycobacterium chelonae-abscessus complex, we reidentified M. bolletii strains isolated from 4 respiratory patients and found these strains to be uniformly resistant to ...

Main Category: Respiratory / Asthma Also Included In: Infectious Diseases / Bacteria / Viruses ; Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials Article Date: 04 Dec 2008 - 0:00 PST Advanced ...